DE60308810D1 - Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin - Google Patents

Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin

Info

Publication number
DE60308810D1
DE60308810D1 DE60308810T DE60308810T DE60308810D1 DE 60308810 D1 DE60308810 D1 DE 60308810D1 DE 60308810 T DE60308810 T DE 60308810T DE 60308810 T DE60308810 T DE 60308810T DE 60308810 D1 DE60308810 D1 DE 60308810D1
Authority
DE
Germany
Prior art keywords
leucin
excitement
vivo synthesis
compositions containing
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308810T
Other languages
English (en)
Other versions
DE60308810T2 (de
Inventor
George Verlaan
Leonardus Smeets
Reese Wolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Application granted granted Critical
Publication of DE60308810D1 publication Critical patent/DE60308810D1/de
Publication of DE60308810T2 publication Critical patent/DE60308810T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60308810T 2002-12-20 2003-12-15 Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin Expired - Lifetime DE60308810T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US325711 1981-11-30
US10/325,711 US7288570B2 (en) 2002-12-20 2002-12-20 Stimulation of in vivo production of proteins
PCT/NL2003/000892 WO2004056208A1 (en) 2002-12-20 2003-12-15 Stimulation of in vivo production of proteins with formulation comprising leucine

Publications (2)

Publication Number Publication Date
DE60308810D1 true DE60308810D1 (de) 2006-11-16
DE60308810T2 DE60308810T2 (de) 2007-08-02

Family

ID=32593858

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308810T Expired - Lifetime DE60308810T2 (de) 2002-12-20 2003-12-15 Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin

Country Status (12)

Country Link
US (2) US7288570B2 (de)
EP (1) EP1455603B1 (de)
JP (1) JP2006510711A (de)
CN (1) CN100353866C (de)
AT (1) ATE341226T1 (de)
AU (1) AU2003290447B2 (de)
CA (1) CA2510760C (de)
DE (1) DE60308810T2 (de)
DK (1) DK1455603T3 (de)
ES (1) ES2274299T3 (de)
HK (1) HK1065447A1 (de)
WO (1) WO2004056208A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
ES2358045T3 (es) * 2005-01-18 2011-05-05 Dsm Ip Assets B.V. Nuevas composiciones neutracéuticas.
EP1774973A1 (de) * 2005-10-12 2007-04-18 Nutricia N.V. Leucinreiche Zusammentsetzung
WO2007051134A2 (en) * 2005-10-26 2007-05-03 Hill's Pet Nutrition, Inc. Compositions and methods for increasing lean muscle mass and/or reducing fat gain
ES2302463B1 (es) * 2006-12-29 2009-06-05 Madaus, S.A. "composicion a base de fibra de cacao".
CN101657106B (zh) * 2007-02-23 2013-02-06 希尔氏宠物营养品公司 用于控制动物体重的组合物和方法
EP2098126A1 (de) * 2008-03-03 2009-09-09 Nestec S.A. Kohlenhydratstange
EP2098124A1 (de) * 2008-03-03 2009-09-09 Nestec S.A. Kohlenhydratgel
EP2098125B1 (de) * 2008-03-03 2011-10-05 Nestec S.A. Gelförmiges Nahrungsmittel mit hoher Kohlenhydrat-Einlasseffizienz
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
PL2298090T3 (pl) 2009-08-26 2016-07-29 Jeffrey M Golini Kompozycja farmaceutyczna lub nutraceutyczna
PT2327315E (pt) * 2009-11-29 2014-01-14 Nestec Sa Protocolos de dosagem para aumentar a síntese de proteína num indivíduo activo
EP2327316B1 (de) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Verfahren zur steigerung der muskelproteinsynthese
WO2011078654A1 (en) * 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
IN2012DN06588A (de) 2010-02-10 2015-10-23 Novartis Ag
RU2012143622A (ru) * 2010-03-12 2014-04-20 Нестек С.А. Композиции для маскировки вкуса нутриентов и способы их изготовления
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
US8623924B2 (en) 2011-07-15 2014-01-07 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9198454B2 (en) * 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
JP2015518470A (ja) 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
US9598474B2 (en) 2012-03-26 2017-03-21 Axcella Health, Inc. Nutritive fragments, proteins and methods
WO2013148329A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
AU2013240271A1 (en) 2012-03-26 2014-10-02 Axcella Health Inc. Nutritive fragments, proteins and methods
AU2013344753B2 (en) 2012-11-13 2018-09-27 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
CA2902879C (en) 2013-03-15 2023-09-26 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
LT3021690T (lt) * 2013-06-10 2017-07-10 N.V. Nutricia Raumenų išsaugojimas viršsvorį turintiems arba nutukusiems suaugusiams svorio metimo programos metu
KR20160056941A (ko) 2013-09-25 2016-05-20 프로뉴트리아 바이오사이언시스, 인코퍼레이티드 당뇨병 및 비만의 예방 및 치료를 위한 조성물 및 제형, 그리고 글루코스 및 열량 제어에서 이들의 생성방법 및 용도
SG11201607075TA (en) 2014-02-27 2016-09-29 Nusirt Sciences Inc Compositions and methods for the reduction or prevention of hepatic steatosis
US20170258791A1 (en) 2014-08-29 2017-09-14 Project Pm Co., Ltd. Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
RU2601406C1 (ru) * 2015-11-17 2016-11-10 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Медицинский Университет Имени В.И. Разумовского" Министерства Здравоохранения Российской Федерации Средство, обладающее антикахексическим, противоопухолевым свойствами и снижающее уровень эндогенной интоксикации
JP6105111B1 (ja) 2016-03-02 2017-03-29 国立大学法人東北大学 自閉スペクトラム症改善用組成物
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CU20200012A7 (es) 2017-08-14 2021-02-04 Axcella Health Inc Composiciones de aminoácidos para el tratamiento de enfermedad hepática
CH714189A1 (de) * 2017-09-25 2019-03-29 Omanda Ag Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung.
US11273138B2 (en) 2017-11-02 2022-03-15 Bioventures, Llc Use of amino acid supplementation for improved muscle protein synthesis
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
CH715997A1 (de) * 2019-03-25 2020-09-30 Omanda Ag Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928445A (en) * 1973-12-26 1975-12-23 Allied Chem Synthesis of 2-halo-5-cyano alkyl valerate
JPS6049764A (ja) * 1983-08-29 1985-03-19 Ajinomoto Co Inc 食品組成物
JPS60186261A (ja) * 1984-03-06 1985-09-21 Ajinomoto Co Inc 固体状食品組成物
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FI892006A (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
US5242697A (en) * 1990-10-26 1993-09-07 Maurizio Luca Method of preparing nutrified food products
JP3622271B2 (ja) 1995-07-11 2005-02-23 味の素株式会社 馬用栄養組成物
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
DE29707308U1 (de) 1997-04-23 1997-06-26 Kunz Armin Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US6221418B1 (en) * 1999-03-25 2001-04-24 Focused Foods, Inc. High protein edible composition and method of preparing the same
US6241996B1 (en) * 1999-04-09 2001-06-05 Novartis Nutrition Ag Liquid soy nutritional products
ATE320724T1 (de) 1999-12-30 2006-04-15 Kerry Group Services Ltd Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung
US6521591B1 (en) 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US6706295B2 (en) * 2000-09-29 2004-03-16 The Procter & Gamble Co. Compositions comprising arabinogalactan and a defined protein component
GB0110288D0 (en) 2001-04-26 2001-06-20 Novartis Nutrition Ag Composition and treatment method
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins

Also Published As

Publication number Publication date
US20040122097A1 (en) 2004-06-24
CN100353866C (zh) 2007-12-12
ES2274299T3 (es) 2007-05-16
US20080161398A1 (en) 2008-07-03
AU2003290447A2 (en) 2005-08-25
EP1455603B1 (de) 2006-10-04
CA2510760A1 (en) 2004-07-08
DE60308810T2 (de) 2007-08-02
US7288570B2 (en) 2007-10-30
AU2003290447B2 (en) 2007-10-04
DK1455603T3 (da) 2007-02-05
CA2510760C (en) 2011-09-20
EP1455603A1 (de) 2004-09-15
JP2006510711A (ja) 2006-03-30
AU2003290447A1 (en) 2004-07-14
HK1065447A1 (en) 2005-02-25
WO2004056208A1 (en) 2004-07-08
CN1753625A (zh) 2006-03-29
ATE341226T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
DE60308810D1 (de) Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin
Pal et al. Sustainable valorisation of seafood by-products: Recovery of collagen and development of collagen-based novel functional food ingredients
NZ569989A (en) Food product comprising a proline specific protease, the preparation thereof and its use for degrading toxic or allergenic gluten peptides
EP2263470A3 (de) Zuführung von funktionellen Zutaten
EP0922395A4 (de) Produkt mit einem gesundheitsfördernden ingredient und verfahren zu seiner herstellung
NO20022061D0 (no) Fremgangsmåte for å fremstille produkter inneholdende antihypertensive tripeptider
MXPA04005993A (es) Producto alimenticio que contiene capsulas o tabletas de gel.
WO2006105284A3 (en) Yeast fermentation of rice bran extracts
MXPA04000834A (es) Suplementos dieteticos de vinasa de vino y un proceso importante de produccion.
HUP0202395A2 (hu) Szőlőmagok, hidegen préselt szőlőmagolaj, szőlőmagdara és szőlőmagliszt
Jensen et al. The potential of cod hydrolyzate to inhibit blood pressure in spontaneously hypertensive rats
EP1604659A4 (de) Tablette mit wasseraufnehmender aminosäure
JP4676448B2 (ja) タンパク質分解酵素阻害因子発現増強剤及びそれを含む皮膚の保水率改善剤
BR0103639A (pt) Produção microbiana de ácido l-ascórbico e ácido d-eritárbico
MY179236A (en) Skin collagen production-promoting agent
ATE319789T1 (de) Verwendung von anti-adhäsiven verpackungsmaterialien für die verpackung von chemikalien und lebensmitteln
TW200633645A (en) Increase in the protein proportion of animal organisms
JP5980519B2 (ja) Ａｍｐｋ活性化剤
ATE391510T1 (de) Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii
JP2010120946A (ja) 抗炎症組成物
ATE420652T1 (de) Verwendung omega-3-fettsäurehaltiger öle zur erhöhung der bioverfügbarkeit von pflanzenextrakten
ATE417619T1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
PT1289931E (pt) Sais duplos de acido fumarico com uma carnitina e um aminoacido e suplementos alimentares, suplementos dieteticos e farmacos contendo os mesmos
BR0309247A (pt) Produto alimentìcio apropriado para fritura e seu uso
Zapata et al. Antioxidant and Antiproliferative Activity of Enzymatic Hydrolysates From Red Tilapia (Oreochromis spp.) Viscera

Legal Events

Date Code Title Description
8364 No opposition during term of opposition